Core Insights - PRF Technologies has undergone a significant transformation in 2025, repositioning itself as a diversified innovation platform in healthcare and renewable energy analytics [3] - The company made a majority investment in LayerBio, enhancing its healthcare pipeline with the OcuRing™-K, aimed at improving cataract surgery outcomes [4][5] - DeepSolar, acquired in March 2025, has transitioned from an acquisition to a commercial entity, focusing on AI-driven solar analytics [9][10] Healthcare Business Update - PRF's healthcare strategy evolved with the acquisition of LayerBio, expanding its focus to sustained-release ocular drug delivery [4] - OcuRing™-K is designed to deliver ketorolac during cataract surgery, potentially reducing the need for post-surgical eye drops [5][6] - The company is progressing towards a Phase II study for OcuRing™-K, with favorable safety data from preclinical and Phase I evaluations [5][6] DeepSolar Business Update - DeepSolar has launched a strategic pilot with Econergy at a 92 MW photovoltaic plant in Romania, leading to its first commercial customer agreement [10] - The company has developed a Smart Energy Management app and entered into a SaaS agreement for a 71 MW solar project in Romania [10][11] - DeepSolar's advancements reflect its growth in commercial deployment and analytics-driven solutions for solar asset management [12] Financial Results - Research and development expenses decreased to approximately $1.1 million in 2025 from $11.7 million in 2024, primarily due to reduced clinical trial costs [13] - General and administrative expenses remained stable at approximately $3.0 million for both years, with some offsetting factors [14] - The net loss for 2025 was approximately $4.8 million, a significant reduction from a net loss of approximately $14.6 million in 2024 [15]